Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Helen J Birch"'
Autor:
Stephen J Brett, Vishal Patel, Sophie Young, Bethany Levick, Daniel C Gibbons, Tahereh Kamalati, Myriam Drysdale, Evgeniy R Galimov, Marcus James Yarwood, Jonathan D Watkins, Benjamin F Pierce, Emily J Lloyd, William Kerr, Helen J Birch
Publikováno v:
BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
Background We assessed the effectiveness of sotrovimab vs no early COVID-19 treatment in highest-risk COVID-19 patients during Omicron predominance.Methods Retrospective cohort study using the Discover dataset in North West London. Included patients
Externí odkaz:
https://doaj.org/article/63c9ad243a8c40aca8bd08c0e7ef1fac
Autor:
Christopher F Bell, Daniel C Gibbons, Myriam Drysdale, Helen J Birch, Emily J Lloyd, Vishal Patel, Corinne Carpenter, Katherine Carlson, Ediz S Calay, Arjun Puranik, Tyler E Wagner, John C O'Horo, Raymund R Razonable
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0304822 (2024)
BackgroundTo describe outcomes of high-risk patients with coronavirus disease 2019 (COVID-19) treated with sotrovimab, other monoclonal antibodies (mAbs), or antivirals, and patients who did not receive early COVID-19 treatment. We also evaluate the
Externí odkaz:
https://doaj.org/article/40b9c0a553614aab870c96814abcc136
Autor:
Sacha Satram, Parima Ghafoori, Carolina M. Reyes, Tom J. H. Keeley, Helen J. Birch, Dimitra Brintziki, Melissa Aldinger, Elizabeth Alexander, Amanda Lopuski, Elias H. Sarkis, Anil Gupta, Adrienne E. Shapiro, John H. Powers
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-11 (2023)
Abstract Background The COMET-ICE trial demonstrated that sotrovimab clinically and statistically significantly reduces the risk of all-cause > 24-h hospitalization or death due to any cause among patients with COVID-19 at high risk of disease progre
Externí odkaz:
https://doaj.org/article/6f5b2215640644699e5c1eb8151e8b5b
Autor:
Tom J. H. Keeley, Sacha Satram, Parima Ghafoori, Carolina Reyes, Helen J. Birch, Kimberly Raymond, Heather L. Gelhorn, Mark Kosinski, Cory D. Saucier, April Mitchell Foster, Amanda Lopuski, John H. Powers
Publikováno v:
Quality of Life Research. 32:1645-1657
Purpose A well-defined and reliable patient-reported outcome instrument for COVID-19 is important for assessing symptom severity and supporting research studies. The InFLUenza Patient-Reported Outcome (FLU-PRO) instrument has been expanded to include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82eda0885507b6919cd5fea2b0f647b2
https://doi.org/10.1007/s11136-022-03336-3
https://doi.org/10.1007/s11136-022-03336-3
Autor:
Vishal Patel, Bethany Levick, Stephen Boult, Daniel C. Gibbons, Myriam Drysdale, Emily J. Lloyd, Moushmi Singh, Helen J. Birch
IntroductionThere is limited real-world evidence describing the effectiveness of early treatments for Coronavirus disease 2019 (COVID-19) during the period where Omicron was the dominant variant. Here we describe characteristics and acute clinical ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::102a4182291b3bbe68462a014ecac6ed
https://doi.org/10.1101/2023.02.08.23285654
https://doi.org/10.1101/2023.02.08.23285654
Autor:
Vishal Patel, Marcus J. Yarwood, Bethany Levick, Daniel C. Gibbons, Myriam Drysdale, William Kerr, Jonathan D. Watkins, Sophie Young, Benjamin F. Pierce, Emily J. Lloyd, Helen J. Birch, Tahereh Kamalati, Stephen J. Brett
IntroductionThere is limited real-world evidence surrounding the effectiveness of early, mild-to-moderate COVID-19 treatments following the emergence and dominance of Omicron SARS-CoV-2 subvariants. Here, characteristics and acute clinical outcomes a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef5abb5926baa2f04e0e034c48e6d5ae
https://doi.org/10.1101/2022.11.28.22282808
https://doi.org/10.1101/2022.11.28.22282808
Publikováno v:
Acute critical care.
Background: COVID-19, due to its deadly nature and rapid spread, is causing significant global economic burden. Aim: To summarize emerging data on direct costs associated with disease management of COVID-19. Methods: A targeted review of the literatu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95fe7bdc7a7dd54a1daf2bf29c32fbd6
https://doi.org/10.1183/13993003.congress-2021.pa3769
https://doi.org/10.1183/13993003.congress-2021.pa3769
Autor:
Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C. Gibbons, Emily J. Lloyd, William Kerr, Calum Macdonald, Helen J. Birch, Aziz Sheikh
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The clinical benefit of coronavirus disease 2019 (COVID-19) treatments against new circulating variants remains unclear. We sought to describe characteristics and clinical outcomes of highest risk patients with COVID-19 receiving
Externí odkaz:
https://doaj.org/article/e6f97d2fec77487f82c4dc9b302868dd
Autor:
Vishal Patel, Bethany Levick, Stephen Boult, Daniel C. Gibbons, Myriam Drysdale, Emily J. Lloyd, Moushmi Singh, Helen J. Birch
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background The impact of the constantly evolving severe acute respiratory syndrome coronavirus 2 on the effectiveness of early coronavirus disease 2019 (COVID-19) treatments is unclear. Here, we report characteristics and acute clinical outc
Externí odkaz:
https://doaj.org/article/9ffce5c4ddc843bca1345684dccb61e5